开放科学和透明度是我们打击欺诈出版活动的最有力工具。

IF 9.9 1区医学 Q1 Medicine

PLoS Medicine Pub Date : 2025-09-26 eCollection Date: 2025-09-01 DOI:10.1371/journal.pmed.1004774

Helen Lumbard, Daniel Routledge

{"title":"开放科学和透明度是我们打击欺诈出版活动的最有力工具。","authors":"Helen Lumbard, Daniel Routledge","doi":"10.1371/journal.pmed.1004774","DOIUrl":null,"url":null,"abstract":"Systematic fraud threatens the integrity of science, with paper and review mills distorting the evidence base in medicine and global health. Data transparency-once seen mainly as a driver of discovery-must now be recognized as a frontline defense against misconduct. Only through open data and coordinated action can we safeguard trust in research and its impact on health.","PeriodicalId":49008,"journal":{"name":"PLoS Medicine","volume":"22 9","pages":"e1004774"},"PeriodicalIF":9.9000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12483235/pdf/","citationCount":"0","resultStr":"{\"title\":\"Open science and transparency are our strongest tools in the fight against fraudulent publishing activities.\",\"authors\":\"Helen Lumbard, Daniel Routledge\",\"doi\":\"10.1371/journal.pmed.1004774\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Systematic fraud threatens the integrity of science, with paper and review mills distorting the evidence base in medicine and global health. Data transparency-once seen mainly as a driver of discovery-must now be recognized as a frontline defense against misconduct. Only through open data and coordinated action can we safeguard trust in research and its impact on health.\",\"PeriodicalId\":49008,\"journal\":{\"name\":\"PLoS Medicine\",\"volume\":\"22 9\",\"pages\":\"e1004774\"},\"PeriodicalIF\":9.9000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12483235/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PLoS Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1371/journal.pmed.1004774\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1371/journal.pmed.1004774","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

系统性的欺诈威胁着科学的完整性，论文和评论工厂扭曲了医学和全球卫生领域的证据基础。数据透明——曾经主要被视为发现的驱动力——现在必须被视为对抗不当行为的一线防线。只有通过开放数据和协调行动，我们才能维护对研究的信任及其对健康的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Open science and transparency are our strongest tools in the fight against fraudulent publishing activities.

Systematic fraud threatens the integrity of science, with paper and review mills distorting the evidence base in medicine and global health. Data transparency-once seen mainly as a driver of discovery-must now be recognized as a frontline defense against misconduct. Only through open data and coordinated action can we safeguard trust in research and its impact on health.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

PLoS Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

17.60

自引率

0.60%

发文量

227

审稿时长

4-8 weeks

期刊介绍： PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.